The Parcel Giant Buys a Cold Chain
A ₹450-crore acquisition pitch. Decide if the synergies are real.
The Prompt
Your client is India's #2 express-parcel company (₹3,800 crore revenue). An investment bank has pitched the acquisition of a regional cold-chain logistics player — 95 reefer trucks, 6 cold warehouses in the South, ₹260 crore revenue, ₹28 crore EBITDA — at an asking price of ₹450 crore. The board wants your view in three weeks.
Opening exchange
Acquisitions need three tests: standalone value (is the asset good?), synergy value (is it worth more to us?), and price versus both. But the prior question — what's the strategic intent? Is the client buying growth, capability, or defence against the #1 player?
Capability. Quick-commerce and pharma clients keep asking the client for cold delivery; it has none. Building greenfield was estimated at 4 years and ₹600 crore to reach equivalent scale.
The build-vs-buy benchmark (₹600 cr, 4 yrs) is gold: it bounds what "control of this capability" is worth before any DCF.
So buy-vs-build already favours buying if this asset is healthy: ₹450 crore now versus ₹600 crore and four lost years. My structure: standalone quality of the target, synergies — both revenue and cost, each sized and probability-weighted — then integration risks, then the price verdict.
Structure & Hypothesis
Analysis & Data
Work the synergies. The client has 1,100 corporate accounts; the bank claims 8% would buy cold-chain services averaging ₹40 lakh a year each. Cost side: 30 of the target's line-haul routes overlap with the client's network, ₹35 lakh annual saving per overlapping route.
Revenue claim: 88 accounts × ₹40 lakh = ₹35 crore of new revenue — at the target's ~11% margin, ~₹4 crore EBITDA. But banker cross-sell rates are fantasy; haircut to 3–4% adoption: ~₹1.5–2 crore EBITDA, ramping over 3 years. Cost: 30 routes × ₹35 lakh = ₹10.5 crore — these I'd weight 70–80% because route consolidation is within our control: ~₹8 crore. Total credible synergy EBITDA ≈ ₹10 crore, not the bank's ~₹15 crore.
Differential probability weighting: cost synergies (we control) get high weights; revenue synergies (customers decide) get savage haircuts.
So is ₹450 crore fair?
Standalone: ₹28 crore at a 12× regional-logistics multiple ≈ ₹336 crore. Synergized: (28+10) × 12 ≈ ₹456 crore — the ask equals full synergy value, meaning the seller captures everything we'd create. I'd counter at ₹370–390 crore — standalone plus roughly half the cost synergies — and walk above ₹420 unless DD reveals upside. One more lens: even at ₹450 it beats the ₹600-crore greenfield, but "cheaper than the worst alternative" isn't the bar; creating value for our shareholders is.
Recommendation
Recommend to the board
- Pursue the deal — capability logic and buy-vs-build both hold — but not at ₹450 crore; open at ₹370 crore, walk at ₹420.
- Make DD kill-or-confirm three things: client contracts surviving founder exit (key-man clauses), reefer fleet age/maintenance records, and pharma cold-cert compliance.
- Structure protection: 15–20% of consideration as earn-out tied to client retention at 24 months.
- Pre-plan integration around the 30 overlapping routes — the cost synergy is the only one we fully control, so capture it in the first year.
Key Takeaway
What this case teaches
Value the target three times — standalone, synergized, and versus the ask — and probability-weight synergies by who controls them: cost synergies you control, revenue synergies the customer controls. Whoever pays full synergy value has transferred the deal's entire upside to the seller.